Position in GSK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$597,391,371
-$49,303,688 QoQ
Shares Held
11,396,249
-2.7% QoQ
Ownership
0.569%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#5
of 1,033 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $41,461,553,100 across 12 Drug Manufacturers - General names. GSK ranks #10 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,998,953 | $13,192,475,293 | |
| 2 | MRK |
Merck & Co., Inc.
|
86,249,283 | $11,083,032,864 | |
| 3 | JNJ |
Johnson & Johnson
|
22,588,696 | $5,736,851,118 | |
| 4 | AZN |
Astrazeneca PLC
|
28,537,243 | $5,411,232,013 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
12,699,683 | $1,604,477,945 | |
| 6 | ABBV |
AbbVie Inc.
|
5,055,589 | $1,272,188,413 | |
| 7 | AMGN |
Amgen Inc
|
2,742,271 | $993,031,171 | |
| 8 | BIIB |
Biogen Inc.
|
3,117,469 | $673,560,350 |
All Filings in GSK
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $597,391,371 | 11,396,249 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $646,695,059 | 11,717,613 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $615,819,160 | 12,557,487 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $147,621,008 | 3,420,320 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $55,860,824 | 1,454,709 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $74,299,055 | 1,917,890 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $70,822,629 | 2,094,105 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $77,837,888 | 1,904,058 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $79,465,154 | 2,064,030 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $67,317,344 | 1,570,267 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $38,676,703 | 1,043,624 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $33,081,857 | 912,603 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $33,769,646 | 947,521 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $36,835,794 | 1,035,295 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $35,645,942 | 1,014,398 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $23,663,837 | 804,072 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||